Vietnam Vaccine Joint Stock Company (VNVC) has officially signed a contract with Germany's Rieckermann Group, a world leader in vaccine and pharmaceutical plant design, to develop a state-of-the-art vaccine and biopharmaceutical production facility, Radio the Voice of Vietnam reported. The VNVC vaccine and biopharmaceutical plant represents a significant investment of approximately VND2 trillion ($78.7 million).